Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Submitted by
admin
on May 18, 2017 - 12:02am
Source:
Endpoints
News Tags:
Syndax Pharma
clinical trials
entinostat
non-small cell lung cancer
Headline:
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Do Not Allow Advertisers to Use My Personal information
